Combination mRNA COVID-Influenza Shot Recommended by European Medicines Agency
The European Medicine Agency (EDA) has recommended marketing authorization for Moderna’s mCombriax mRNA (messenger ribonucleic acid) shot. The product, also known as mRNA-1083, is a genetically engineered biologic targeting both influenza and COVID-19. It builds on work Moderna has done on its next-generation mRNA COVID shot known as mNexSpike and mRNA-1010.1 2 3 The recommendation […]
European Medicines Agency Issues Support for New Recombinant Pertussis Vaccine
A new pertussis vaccine, which has been designed to be used as a booster and for vaccinating pregnant women, has received “positive regulatory support” from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). Marketed under the name VacPertagen, the recombinant pertussis vaccine—formulated with genetically engineered proteins rather than inactivated whole […]
Cholera Vaccine Recommended by European Medicines Agency
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of the single-dose oral cholera vaccine Vaxchora, developed by multinational biopharmaceutical firm Emergent BioSolutions, Inc. of Gaithersburg, Maryland. On Jan. 30, 2020, the CHMP adopted a “positive opinion” on the granting of a marketing authorization for the bacterial […]